Ipsen Zukünftiges Wachstum

Future Kriterienprüfungen 1/6

Ipsen wird ein jährliches Gewinn- und Umsatzwachstum von 7% bzw. 5.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 6.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 14.8% betragen.

Wichtige Informationen

7.0%

Wachstumsrate der Gewinne

6.9%

EPS-Wachstumsrate

Pharmaceuticals Gewinnwachstum17.1%
Wachstumsrate der Einnahmen5.5%
Zukünftige Eigenkapitalrendite14.8%
Analystenabdeckung

Good

Zuletzt aktualisiert04 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

What Ipsen S.A.'s (EPA:IPN) P/E Is Not Telling You

Sep 30
What Ipsen S.A.'s (EPA:IPN) P/E Is Not Telling You

These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

Sep 08
These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

An Intrinsic Calculation For Ipsen S.A. (EPA:IPN) Suggests It's 42% Undervalued

Jun 16
An Intrinsic Calculation For Ipsen S.A. (EPA:IPN) Suggests It's 42% Undervalued

Ipsen (EPA:IPN) Has Announced A Dividend Of €1.20

May 29
Ipsen (EPA:IPN) Has Announced A Dividend Of €1.20

We Think Shareholders May Consider Being More Generous With Ipsen S.A.'s (EPA:IPN) CEO Compensation Package

May 22
We Think Shareholders May Consider Being More Generous With Ipsen S.A.'s (EPA:IPN) CEO Compensation Package

Ipsen (EPA:IPN) Has Affirmed Its Dividend Of €1.20

May 08
Ipsen (EPA:IPN) Has Affirmed Its Dividend Of €1.20

Ipsen (EPA:IPN) Has Affirmed Its Dividend Of €1.20

Apr 20
Ipsen (EPA:IPN) Has Affirmed Its Dividend Of €1.20

There's Reason For Concern Over Ipsen S.A.'s (EPA:IPN) Price

Apr 13
There's Reason For Concern Over Ipsen S.A.'s (EPA:IPN) Price

Ipsen (EPA:IPN) Seems To Use Debt Quite Sensibly

Mar 26
Ipsen (EPA:IPN) Seems To Use Debt Quite Sensibly

Investors Still Waiting For A Pull Back In Ipsen S.A. (EPA:IPN)

Dec 30
Investors Still Waiting For A Pull Back In Ipsen S.A. (EPA:IPN)

These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

Dec 11
These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

Are Investors Undervaluing Ipsen S.A. (EPA:IPN) By 31%?

Sep 28
Are Investors Undervaluing Ipsen S.A. (EPA:IPN) By 31%?

These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

Sep 07
These 4 Measures Indicate That Ipsen (EPA:IPN) Is Using Debt Reasonably Well

Is There An Opportunity With Ipsen S.A.'s (EPA:IPN) 34% Undervaluation?

Jun 21
Is There An Opportunity With Ipsen S.A.'s (EPA:IPN) 34% Undervaluation?

Ipsen (EPA:IPN) Is Due To Pay A Dividend Of €1.20

Jun 02
Ipsen (EPA:IPN) Is Due To Pay A Dividend Of €1.20

Ipsen's (EPA:IPN) Dividend Will Be €1.20

May 12
Ipsen's (EPA:IPN) Dividend Will Be €1.20

Ipsen S.A. (EPA:IPN) Shares Could Be 48% Below Their Intrinsic Value Estimate

Mar 19
Ipsen S.A. (EPA:IPN) Shares Could Be 48% Below Their Intrinsic Value Estimate

Ipsen (EPA:IPN) Has A Pretty Healthy Balance Sheet

Mar 01
Ipsen (EPA:IPN) Has A Pretty Healthy Balance Sheet

Ipsen (EPA:IPN) Ticks All The Boxes When It Comes To Earnings Growth

Jan 19
Ipsen (EPA:IPN) Ticks All The Boxes When It Comes To Earnings Growth

Is There An Opportunity With Ipsen S.A.'s (EPA:IPN) 46% Undervaluation?

Dec 08
Is There An Opportunity With Ipsen S.A.'s (EPA:IPN) 46% Undervaluation?

We Think Ipsen (EPA:IPN) Can Manage Its Debt With Ease

Nov 02
We Think Ipsen (EPA:IPN) Can Manage Its Debt With Ease

Does Ipsen (EPA:IPN) Deserve A Spot On Your Watchlist?

Oct 14
Does Ipsen (EPA:IPN) Deserve A Spot On Your Watchlist?

Does Ipsen (EPA:IPN) Have A Healthy Balance Sheet?

Aug 01
Does Ipsen (EPA:IPN) Have A Healthy Balance Sheet?

Here's Why We Think Ipsen (EPA:IPN) Might Deserve Your Attention Today

Jul 10
Here's Why We Think Ipsen (EPA:IPN) Might Deserve Your Attention Today

Ipsen (EPA:IPN) Will Pay A Larger Dividend Than Last Year At €1.20

May 26
Ipsen (EPA:IPN) Will Pay A Larger Dividend Than Last Year At €1.20

Gewinn- und Umsatzwachstumsprognosen

ENXTPA:IPN - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20263,9328028481,10911
12/31/20253,6867307941,02012
12/31/20243,49062763084913
6/30/20243,435664425903N/A
3/31/20243,371641554884N/A
12/31/20233,306617683866N/A
6/30/20233,282406764972N/A
3/31/20233,219500741971N/A
12/31/20223,156593719971N/A
9/30/20223,053656615972N/A
6/30/20222,950719512973N/A
3/31/20222,849675494933N/A
12/31/20212,749631475893N/A
9/30/20212,712626570860N/A
6/30/20212,676622665827N/A
3/31/20212,681585649799N/A
12/31/20202,686548632771N/A
9/30/20202,697249564750N/A
6/30/20202,707-50496729N/A
3/31/20202,700-53421678N/A
12/31/20192,693-55347628N/A
9/30/20192,605176310591N/A
6/30/20192,516406272555N/A
3/31/20192,432397279563N/A
12/31/20182,348388285571N/A
9/30/20182,258365N/AN/AN/A
6/30/20182,167343280502N/A
3/31/20182,090307N/A463N/A
12/31/20172,012270N/A423N/A
9/30/20171,923243N/AN/AN/A
6/30/20171,834217N/A316N/A
3/31/20171,753221N/A317N/A
12/31/20161,671226N/A318N/A
9/30/20161,623229N/AN/AN/A
6/30/20161,575233N/A318N/A
3/31/20161,548211N/A271N/A
12/31/20151,520189N/A224N/A
9/30/20151,468165N/A225N/A
6/30/20151,416140N/A227N/A
3/31/20151,374147N/A237N/A
12/31/20141,332154N/A246N/A
9/30/20141,310155N/A217N/A
6/30/20141,287156N/A188N/A
3/31/20141,284149N/A188N/A
12/31/20131,282142N/A188N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: IPNDas prognostizierte Gewinnwachstum (7% pro Jahr) liegt über der Sparquote (1.4%).

Ertrag vs. Markt: IPNDie Erträge des Unternehmens (7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (12.5% pro Jahr).

Hohe Wachstumserträge: IPNDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: IPNDie Einnahmen des Unternehmens (5.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt French (5.6% pro Jahr).

Hohe Wachstumseinnahmen: IPNDie Einnahmen des Unternehmens (5.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: IPNDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (14.8%).


Wachstumsunternehmen entdecken